Phreesia
Edit

Phreesia

http://www.phreesia.com/
Last activity: 15.08.2023
Tags:CareContentFinTechHealthTechInformationInsurTechMedTechOptimizePlatformTime
Leading healthcare organizations choose Phreesia to revolutionize their point of service. Regardless of size, specialty or demographics, today’s healthcare systems face the same challenges: escalating demands, rising costs and increasing patient responsibility. Phreesia’s innovative point-of-service platform—including patient self-service and mobile applications—resolves these issues by driving efficiency and profitability throughout your organization. Your patients expect a seamless, automated experience from other industries. Why should your front office be any different?
Likes
995
Mentions
39
Location: United States, North Carolina, Raleigh
Employees: 1001-5000
Phone: +1 888-654-7473
Total raised: $63.6M
Founded date: 2005
Facebook
Instagram
LinkedIn
Email

Investors 6

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
23.10.2014-$30M-finsmes.co...
28.09.2010Series D$6M-finsmes.co...
26.05.2010Series D$16M-finsmes.co...
17.02.2009-$11.6M-venturebea...

Mentions in press and media 39

DateTitleDescriptionSource
15.08.2023Phreesia Acquires Access eFormsPhreesia, a Wilmington, DE-based company which specializes in patient intake, outreach and activatio...finsmes.co...
17.07.2023Phreesia Acquires MediFind, Reinforcing its Commitment to Pa...Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquire...aithority....
17.07.2023Phreesia Buys MediFindPhreesia, a Wilmington, DE-based company which specializes in patient intake, outreach and activatio...finsmes.co...
23.11.2021At busy Visp site, Lon­za will up mi­cro­bial ser­vices by 5...In an ef­fort to up its de­vel­op­ment of mi­cro­bial-de­rived pro­teins, Swiss CD­MO Lon­za will in...endpts.com...
23.11.2021Vac­ci­body gets a new name and loads up with near­ly $1B in...Vac­ci­body who? A lit­tle over a year af­ter se­cur­ing a $700 mil­lion-plus deal with Roche for it...endpts.com...
23.11.2021FDA ap­proves pricey new treat­ment for ul­tra-rare and ag­g...Forget the migraine marketing brand wars. When it comes to patients, many can’t even name one despit...endpts.com...
23.11.2021FDA ap­proves pricey new treat­ment for ul­tra-rare and ag­g...After a wild two-decade ride, the FDA has approved Takeda’s antiviral maribavir — now marketed as Li...endpts.com...
23.11.2021FDA ap­proves pricey new treat­ment for ul­tra-rare and ag­g...President Biden’s nominee to run the FDA was hit with some tepid criticism back in 2016 for being to...endpts.com...
23.11.2021A fledg­ling transpa­cif­ic biotech grabs a launch round to ...Pre­ci­sion-med biotech Al­lo­ri­on Ther­a­peu­tics is ex­pand­ing — and now has tens of mil­lions o...endpts.com...
23.11.2021FDA ap­proves pricey new treat­ment for ul­tra-rare and ag­g...Horizon Therapeutics CEO Tim Walbert runs a rare disease company, but he’s also a patient. While his...endpts.com...
Show more